Bottom line
BBH vs GNOM: the short answer
BBH (VanEck Biotech ETF) and GNOM (Global X Genomics & Biotechnology ETF) are quite different portfolios: only about 23% of their top holdings (by weight) are shared.
But GNOM is far broader, holding 51 positions to 25 for BBH, so beyond the top names it adds exposure BBH doesn't have.
BBH is cheaper at 0.35% vs 0.5% — a difference of $15 a year per $10,000 invested.
Over five years, BBH returned +2.7% a year vs −13.3% for GNOM.
Updated Nov 19, 2026
BBH vs GNOM side by side
| BBH | GNOM | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | VanEck | Global X |
| Category | Technology Sector | Technology Sector |
| Expense ratio | 0.35% | 0.5% |
| Annual cost per $10k | $35 | $50 |
| 10-yr cost on $10k (prospectus) | $443 | $628 |
| Max front load | None | None |
| 12b-1 fee | — | 0% |
| 1-yr return | +21.2% | +19.0% |
| 5-yr return (annualized) | +2.7% | −13.3% |
| 10-yr return (annualized) | +4.5% | — |
| Best quarter | +27.6% | +38.8% |
| Worst quarter | −18.2% | −24.2% |
| Net assets (fund) | $395.6M | $55.8M |
| Number of holdings | 25 | 51 |
| Portfolio turnover | 19% | 34% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | BBH | GNOM | Difference |
|---|---|---|---|
| 2025 | +21.2% | +19.0% | +2.2% |
| 2024 | −4.4% | −16.2% | +11.8% |
| 2023 | +3.9% | −8.6% | +12.5% |
| 2022 | −15.1% | −36.1% | +21.0% |
| 2021 | +11.8% | −16.0% | +27.8% |
| 2020 | +22.1% | +51.6% | −29.6% |
Source: Fund prospectus bar charts
Holdings overlap
8 of BBH's top 25 holdings also appear in GNOM's top 25.
| Holding | BBH | GNOM |
|---|---|---|
| Gilead Sciences Inc | 12.79% | 1.95% |
| Vertex Pharmaceuticals Inc | 9.10% | 3.95% |
| Natera Inc | 4.92% | 4.15% |
| Moderna Inc | 3.36% | 3.28% |
| Illumina Inc | 3.17% | 4.82% |
| BioNTech SE | 1.94% | 3.41% |
| Bio-Techne Corp | 1.54% | 3.41% |
| BioMarin Pharmaceutical Inc | 1.34% | 4.09% |
Source: SEC Form N-PORT
BBH top 10
- Amgen Inc — 15.25%
- Gilead Sciences Inc — 12.79%
- Vertex Pharmaceuticals Inc — 9.10%
- Regeneron Pharmaceuticals Inc — 6.21%
- Revolution Medicines Inc — 5.27%
- Argenx SE — 4.97%
- Natera Inc — 4.92%
- IQVIA Holdings Inc — 4.31%
- Alnylam Pharmaceuticals Inc — 3.83%
- Biogen Inc — 3.63%
GNOM top 10
- Guardant Health, Inc. — 5.59%
- Illumina, Inc. — 4.82%
- Natera, Inc. — 4.15%
- Biomarin Pharmaceutical Inc. — 4.09%
- Arrowhead Pharmaceuticals, Inc. — 4.07%
- Legend Biotech Corp — 4.05%
- Praxis Precision Medicines Inc — 4.01%
- Twist Bioscience Corp — 3.97%
- Vertex Pharmaceuticals Incorporated — 3.95%
- CRISPR Therapeutics AG — 3.85%
FAQ
What is the difference between BBH and GNOM?
Which is cheaper, BBH or GNOM?
Should I own both BBH and GNOM?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.